Gastroenterology

Gastroenterology

Volume 113, Issue 3, September 1997, Pages 746-754
Gastroenterology

Mast cell involvement in gastritis with or without Helicobacter pylori infection

https://doi.org/10.1016/S0016-5085(97)70167-7Get rights and content

Abstract

BACKGROUND & AIMS: Mast cells are initiators and regulators of inflammation, but their role in the human stomach remains unclear. Therefore, the extent and distribution of mast cell involvement in gastritis with or without Helicobacter pylori infection was investigated. METHODS: Mapped biopsy specimens from 17 H. pylori- positive and 20 H. pylori-negative subjects were examined. Sections were assessed for infection and inflammation and stained with anti- human mast cell tryptase to count mucosal and epithelial mast cells. Density of mast cells in different gastric compartments, their response to infection treatment, and their relationship with other inflammatory cells were evaluated. Mast cell degranulation was evaluated by electron microscopy. RESULTS: Mast cell density was significantly greater in the mucosa with gastritis, with or without H. pylori infection, than in the mucosa of noninfected normal subjects. In the antrum, density was much greater in H. pylori-infected peptic ulcer subjects than in the other gastritis groups. It also correlated significantly with the intensity of inflammation. Mast cell degranulation was demonstrated by electron microscopy in H. pylori-infected mucosa. Mast cell density in ulcer patients decreased significantly after cure of H. pylori infection. CONCLUSIONS: Mast cells may be important effector cells in the pathogenesis of gastritis, especially in H. pylori-associated peptic ulcer. (Gastroenterology 1997 Sep;113(3):746-54)

References (0)

Cited by (96)

  • Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases

    2018, Journal of Applied Biomedicine
    Citation Excerpt :

    Infiltrating mast cells release different proinflammatory cytokines and chemo-attractants, including PAF, IL-8, LTB4, TNFα, and GM-CSF (granulocyte-monocyte colony stimulating factor) and lead to neutrophil infiltration and inflammatory manifestations (Fig. 1). The mast cells, which are first-line defence of the host, may also contribute to the pathogenesis caused by H. pylori (Supajatura et al., 2002) and act as effector cells in this regard (Nakajima et al., 1997). Basophilic cells (bone-derived mast cells) produce different polyamines such as putrescine and spermine.

  • Mast cells in human digestive tube in normal and pathological conditions

    2016, Immunology Letters
    Citation Excerpt :

    The gastrointestinal MCs perform their biological functions, releasing mediators, as amines (histamine, serotonin), cytokines, proteases, lipid mediators (leukotrienes, prostaglandins), and heparin [17–20]. In the stomach, MCs are distributed mainly in the upper third of the fundic glands portion and in the upper half of the pyloric glands [21]. The intestinal mucosa is coated with a monolayer of epithelial cells, including M cells, goblet cells, Paneth cells, and columnar epithelial cells and is exposed to various stimuli including food materials, commensal and pathogenic microorganisms.

  • Mast cell progenitors: Origin, development and migration to tissues

    2015, Molecular Immunology
    Citation Excerpt :

    Mast cells in tissues are very long-lived (Padawer, 1974) and even after degranulation they re-granulate and live on (Walker, 1961; Kobayasi and Asboe-Hansen, 1969; Xiang et al., 2001). Many studies report on organ-specific increases in mast cell numbers in human disease (Patella et al., 1998; Terada and Matsunaga, 2000; Molin et al., 2002; Ribatti et al., 2000; O'Sullivan et al., 2000; Ammit et al., 1997; Brightling et al., 2002; Sugamata et al., 2005; Nakajima et al., 1997). The same pattern is also seen in disease models in mice (Dahlin et al., 2012; Yu et al., 2006; Hallgren et al., 2007; Kakizoe et al., 1999; Chang et al., 2011).

View all citing articles on Scopus
View full text